Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 03:00PM GMT
Release Date Price: $3.15 (-1.87%)
Operator

This presentation has not yet begun. Please consult the schedule and press the play button at the start time. After the presentation, an archive will be available here.

Chris Linthwaite
Fluidigm Corporation - President & CEO

CEO of Fluidigm.

Chris Linthwaite
Fluidigm Corporation - President & CEO

Thanks, Adam. Good morning everyone. I appreciate the invitation from Cowen to present and discuss Fluidigm Corporation this morning. We're going to make a few forward-looking statements. A full listing of our forward-looking statements and disclosures are listed on our website. We also include some non-GAAP information and the use of trademarks.

Fluidigm is really about three things. Our overarching goal or uber goal is about improving life through comprehensive health insights. This really manifests in three material ways. One, we're trying to discover new insights related to health and disease, our technologies are powering that discovery process.

The root -- the overarching goal is to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot